Gonadal steroid regulation of mood: The lessons of premenstrual syndrome

@article{Rubinow2006GonadalSR,
  title={Gonadal steroid regulation of mood: The lessons of premenstrual syndrome},
  author={David R Rubinow and Peter J. Schmidt},
  journal={Frontiers in Neuroendocrinology},
  year={2006},
  volume={27},
  pages={210-216}
}
Progesterone, reproduction, and psychiatric illness.
Gonadal steroids and affective symptoms during in vitro fertilization: Implication for reproductive mood disorders
Sex hormones and biomarkers of neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder
TLDR
Clinical aspects of reproductive cycle events in women with bipolar disorder and preclinical studies are critically reviewed, with a focus on the functional interactions between sex hormones and biomarkers of neuroprotection and neurodegeneration that are thought to be involved in the neurobiology of bipolar disorder.
The role of ovarian steroids in affective disorders
The cytokine-hormone axis – the link between premenstrual syndrome and postpartum depression
TLDR
Hypotheses are developed as to why the symptoms experienced in PMS often subside during pregnancy yet may recur and be exacerbated after birth, giving rise to the symptoms of postpartum depression.
Reproductive Hormones and Stages of Life in Women: Moderators of Mood and Cardiovascular Health
TLDR
In this chapter, menstrually related mood disorders are described, including the role of reproductive hormones and their metabolites, and evidence is provided that histories of abuse or histories of depression predict clinically meaningful subgroups of women with these disorders.
Premenstrual dysphoric disorder: burden of illness and treatment update.
TLDR
Several effective treatment options exist, including serotonergic antidepressant medications and an oral contraceptive that contains ethinyl estradiol and drosperinone and other hormones that suppress ovulation, anxiolytics, cognitive therapy, chasteberry and calcium may be helpful.
...
...

References

SHOWING 1-10 OF 112 REFERENCES
Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects.
Prospective assessment of menstrually related mood disorders.
TLDR
In a preliminary application of this measure to 20 women with self-diagnosed premenstrual syndrome, eight had a mean depression rating during the week before menstruation that was 30% higher than During the week after cessation of menstruation.
Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.
TLDR
In women with premenstrual syndrome, the occurrence of symptoms represents an abnormal response to normal hormonal changes.
Aging-Related Changes in Ovarian Hormones, Their Receptors, and Neuroendocrine Function
TLDR
The literature on the causes and consequences of alterations in steroid hormones, their neural receptors, and their interactions on reproductive senescence are reviewed, focusing on rodent models in current use for understanding the mechanisms of menopause in women.
Neurobiological Effects of Sex Steroid Hormones
TLDR
This work focuses on the development and function of sex differences in the brain: the case of Vasopressin, and the role of estrogens and their receptors in this case.
Lack of effect of induced menses on symptoms in women with premenstrual syndrome.
TLDR
The temporal association of typical PMS symptoms with an artificially induced follicular phase suggests that endocrine events during the late luteal phase do not directly generate the symptoms of PMS.
Successful Treatment of Severe Premenstrual Syndrome by Combined Use of Gonadotropin‐Releasing Hormone Agonist and Estrogen/Progestin
TLDR
It is concluded that the undesirable consequence of ovarian steroid deficiency in the treatment of PMS by Gn RH-a can be overcome by the addition of sequential estrogen and progestogen replacements without significantly reducing the effectiveness of GnRH-a in this disorder.
Role of neurotrophic factors in the etiology and treatment of mood disorders
  • R. Duman
  • Psychology, Biology
    NeuroMolecular Medicine
  • 2007
TLDR
The primary work leading to a neurotrophic hypothesis of depression and antidepressant action is reviewed and the cellular mechanisms and signal transduction pathways that underlie these effects are reviewed.
THE USE OF AN LHRH AGONIST, BUSERELIN, IN THE LONG‐TERM MANAGEMENT OF PREMENSTRUAL SYNDROMES
Buserelin, an LHRH agonist, was given by nasal spray to 20 women with premenstrual syndrome. In 10 women benefits were such that they continued treatment for periods varying from 5 to 15 months.
...
...